JP2014518214A5 - - Google Patents

Download PDF

Info

Publication number
JP2014518214A5
JP2014518214A5 JP2014516020A JP2014516020A JP2014518214A5 JP 2014518214 A5 JP2014518214 A5 JP 2014518214A5 JP 2014516020 A JP2014516020 A JP 2014516020A JP 2014516020 A JP2014516020 A JP 2014516020A JP 2014518214 A5 JP2014518214 A5 JP 2014518214A5
Authority
JP
Japan
Prior art keywords
methyl
azaspiro
oxa
oxo
carbonitrile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014516020A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014518214A (ja
JP5969017B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/042622 external-priority patent/WO2013012500A1/en
Publication of JP2014518214A publication Critical patent/JP2014518214A/ja
Publication of JP2014518214A5 publication Critical patent/JP2014518214A5/ja
Application granted granted Critical
Publication of JP5969017B2 publication Critical patent/JP5969017B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014516020A 2011-06-17 2012-06-15 Trpv4拮抗薬 Active JP5969017B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161498110P 2011-06-17 2011-06-17
US61/498,110 2011-06-17
PCT/US2012/042622 WO2013012500A1 (en) 2011-06-17 2012-06-15 Trpv4 antagonists

Publications (3)

Publication Number Publication Date
JP2014518214A JP2014518214A (ja) 2014-07-28
JP2014518214A5 true JP2014518214A5 (enExample) 2015-07-16
JP5969017B2 JP5969017B2 (ja) 2016-08-10

Family

ID=47558389

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014516020A Active JP5969017B2 (ja) 2011-06-17 2012-06-15 Trpv4拮抗薬

Country Status (38)

Country Link
US (1) US9187464B2 (enExample)
EP (2) EP3121177B1 (enExample)
JP (1) JP5969017B2 (enExample)
KR (1) KR101870003B1 (enExample)
CN (1) CN103732583B (enExample)
AR (1) AR086958A1 (enExample)
AU (1) AU2012284540B2 (enExample)
BR (1) BR112013032391B1 (enExample)
CA (1) CA2839743C (enExample)
CL (1) CL2013003602A1 (enExample)
CO (1) CO6821953A2 (enExample)
CR (1) CR20130671A (enExample)
CY (1) CY1117792T1 (enExample)
DK (1) DK2721016T3 (enExample)
DO (1) DOP2013000307A (enExample)
EA (1) EA023616B1 (enExample)
ES (2) ES2688733T3 (enExample)
HR (1) HRP20160539T1 (enExample)
HU (1) HUE029594T2 (enExample)
IL (1) IL229872A (enExample)
JO (1) JO3154B1 (enExample)
MA (1) MA35184B1 (enExample)
ME (1) ME02416B (enExample)
MX (1) MX337440B (enExample)
MY (1) MY173521A (enExample)
PE (1) PE20141943A1 (enExample)
PH (1) PH12013502463A1 (enExample)
PL (1) PL2721016T3 (enExample)
PT (1) PT2721016E (enExample)
RS (1) RS54858B1 (enExample)
SG (1) SG195106A1 (enExample)
SI (1) SI2721016T1 (enExample)
SM (1) SMT201600150B (enExample)
TW (1) TWI538912B (enExample)
UA (1) UA113963C2 (enExample)
UY (1) UY34138A (enExample)
WO (1) WO2013012500A1 (enExample)
ZA (1) ZA201308816B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9487507B2 (en) 2011-06-17 2016-11-08 Glaxosmithkline Intellectual Property (No. 2) Limited TRPV4 antagonists
JP5969015B2 (ja) * 2011-06-17 2016-08-10 グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited Trpv4拮抗薬
WO2013146754A1 (ja) 2012-03-27 2013-10-03 塩野義製薬株式会社 Trpv4阻害活性を有する芳香族複素5員環誘導体
JPWO2015046193A1 (ja) 2013-09-25 2017-03-09 塩野義製薬株式会社 Trpv4阻害活性を有する芳香族複素環式アミン誘導体
KR20190005877A (ko) 2016-05-19 2019-01-16 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 Trpv4 길항제
US10968209B2 (en) 2016-05-19 2021-04-06 Glaxosmithkline Intellectual Property (No.2) Limited TRPV4 antagonist
MX2019003843A (es) 2016-10-03 2019-06-24 Janssen Pharmaceutica Nv Análogos novedosos de carbanucleósidos sustituidos de sistema anular monocíclico y bicíclico para su uso como inhibidores de prmt5.
WO2018185701A1 (en) 2017-04-06 2018-10-11 Glaxosmithkline Intellectual Property (No.2) Limited Trpv4 antagonists as antitussive agents
KR102731924B1 (ko) * 2017-11-01 2024-11-19 브리스톨-마이어스 스큅 컴퍼니 파르네소이드 x 수용체 조정제로서의 스피로시클릭 화합물
WO2021170811A1 (en) 2020-02-27 2021-09-02 Glaxosmithkline Intellectual Property (No.2) Limited Method of treating eye disease using trpv4 antagonists
TWI899220B (zh) 2020-04-30 2025-10-01 日商拉夸里亞創藥股份有限公司 作為trpv4拮抗劑之嘧啶-4(3h)-酮衍生物
CN111704613B (zh) * 2020-06-23 2021-07-06 中国人民解放军军事科学院军事医学研究院 咪唑类衍生物及其作为trpv4抑制剂的用途
EP4183415A4 (en) * 2020-07-16 2024-07-17 RaQualia Pharma Inc. Trpv4 inhibitor as therapeutic drug for eye disease
WO2024011214A1 (en) 2022-07-08 2024-01-11 Actio Biosciences, Inc. Therapeutic compounds and methods
WO2024217446A1 (zh) * 2023-04-18 2024-10-24 河北乌图药业有限公司 化合物及其在慢性乙型肝炎、肝纤维化、肝癌的治疗中的应用
WO2024217439A1 (zh) * 2023-04-18 2024-10-24 河北乌图药业有限公司 化合物及其在慢性乙型肝炎、肝纤维化、肝癌的治疗中的应用
WO2024217452A1 (zh) * 2023-04-18 2024-10-24 河北乌图药业有限公司 化合物及其在慢性乙型肝炎、肝纤维化、肝癌的治疗中的应用
CN120435476A (zh) * 2023-04-18 2025-08-05 河北乌图药业有限公司 化合物及其在慢性乙型肝炎、肝纤维化、肝癌的治疗中的应用
CN120641413A (zh) * 2023-04-18 2025-09-12 河北乌图药业有限公司 化合物及其在慢性乙型肝炎、肝纤维化、肝癌的治疗中的应用
WO2025014818A1 (en) * 2023-07-07 2025-01-16 Actio Biosciences, Inc. Solid forms of gsk2798745, a trpv4 antagonist
CN117945917A (zh) * 2023-12-26 2024-04-30 衢州康鹏化学有限公司 一种3-氟-4-硝基苯甲酸的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061436A1 (en) * 1998-05-26 1999-12-02 Chugai Seiyaku Kabushiki Kaisha Heterocyclic indole derivatives and mono- or diazaindole derivatives
AU2004257289A1 (en) * 2003-07-16 2005-01-27 Neurogen Corporation Biaryl piperazinyl-pyridine analogues
CN101346375B (zh) * 2005-11-23 2013-04-10 阿罗斯药物有限责任公司 调节门离子通道用组合物和方法
WO2007067756A2 (en) 2005-12-08 2007-06-14 Amphora Discovery Corporation Certain chemical entities, compositions, and methods for modulating trpv1
TW201900217A (zh) * 2005-12-22 2019-01-01 美商海卓勒生物科學公司 用於調節trpa1功能之化合物
TW200819457A (en) * 2006-08-30 2008-05-01 Actelion Pharmaceuticals Ltd Spiro antibiotic derivatives
WO2008092888A1 (en) * 2007-02-01 2008-08-07 Glaxo Group Limited 1-oxa-3-azaspiro[4,5]decan--2-one derivatives for the treatment of eating disorders
GB0707934D0 (en) * 2007-04-24 2007-05-30 Glaxo Group Ltd Chemical compounds
JP2010535812A (ja) * 2007-08-09 2010-11-25 アボット・ラボラトリーズ Trpv1拮抗薬としてのテトラヒドロピリジンカルボキサミド誘導体
TW200944520A (en) * 2008-01-29 2009-11-01 Glaxo Group Ltd Spiro compounds as NPY Y5 receptor antagonists
JP5607046B2 (ja) * 2008-07-25 2014-10-15 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー Trpv4拮抗薬
JP2012006837A (ja) * 2008-09-30 2012-01-12 Mochida Pharmaceut Co Ltd 2−インドールアクリルアミド類縁体
EP2605658B1 (en) * 2010-08-18 2016-03-23 Merck Sharp & Dohme Corp. Spiroxazolidinone compounds
US9487507B2 (en) * 2011-06-17 2016-11-08 Glaxosmithkline Intellectual Property (No. 2) Limited TRPV4 antagonists
JP5969015B2 (ja) * 2011-06-17 2016-08-10 グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited Trpv4拮抗薬

Similar Documents

Publication Publication Date Title
JP2014518214A5 (enExample)
HRP20160539T1 (hr) Antagonisti trpv4
CN105339370B (zh) 用于治疗炎症性疾病的化合物和及其药物组合物
JP2014525444A5 (enExample)
KR101439823B1 (ko) 골수증식성 질환 및 기타 증식성 질환의 치료에 유용한 키나제 억제제
ES2642586T3 (es) Compuestos heterocíclicos condensados como moduladores de canales iónicos
JP2021501220A5 (enExample)
US9434743B2 (en) Indazole derivatives
JP2018118992A5 (enExample)
US20230092892A1 (en) Amino quinazoline derivatives as p2x3 inhibitors
JP2014531465A5 (enExample)
JP2013508404A5 (enExample)
JP2014528446A5 (enExample)
JP2019519484A5 (enExample)
US9914736B2 (en) TrKA kinase inhibitors, compositions and methods thereof
HRP20180546T1 (hr) Supstituirani benzilindazoli za uporabu kao inhibitori bub1 kinaze za liječenje hiperproliferativnih bolesti
JP2020527560A5 (enExample)
JP2010502615A5 (enExample)
JP2018534326A5 (enExample)
RU2017105296A (ru) Новые соединения
JP2017500362A5 (enExample)
JP2010524970A5 (enExample)
JP2016500073A5 (enExample)
JP2017500364A5 (enExample)
JP2009536196A5 (enExample)